Strengthening supply chain of anti-D immunoglobulins

View source ↗

Summary

EMA and national health authorities issued recommendations to strengthen the supply chain of anti-D immunoglobulins. The aim is to mitigate vulnerabilities in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Disease of the Fetus and Newborn

Drugs mentioned

• anti-D immunoglobulin (Rh(D) immune globulin)

Snippet

EMA and HMA recommendations to address vulnerabilities in the supply of critical medicines used during pregnancy